{{PBB|geneid=3586}}
'''[[Interleukin]] 10''' ('''IL-10''' or '''IL10'''), also known as '''human cytokine synthesis inhibitory factor''' ('''CSIF'''), is an anti-[[inflammation|inflammatory]] [[cytokine]]. In humans, IL-10 is encoded by the ''IL10'' gene.<ref name="pmid9162098">{{cite journal | author = Eskdale J, Kube D, Tesch H, Gallagher G | title = Mapping of the human IL10 gene and further characterization of the 5' flanking sequence | journal = Immunogenetics | volume = 46 | issue = 2 | pages = 120–8 | year = 1997 | pmid = 9162098 | doi = 10.1007/s002510050250| url = }}</ref>

==Gene and protein structure==
The IL-10 protein is a [[protein dimer|homodimer]]; each of its subunits is 178-[[amino acid|amino-acid]] long.<ref name="pmid8590020">{{cite journal | author = Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J, Wlodawer A | title = Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma | journal = Structure | volume = 3 | issue = 6 | pages = 591–601 | year = 1995 | month = June | pmid = 8590020 | doi = 10.1016/S0969-2126(01)00193-9| url = }}</ref>

IL-10 is classified as a class-2 cytokine, a set of cytokines including IL-19, IL-20, IL-22, IL-24 (Mda-7), and IL-26, interferons (IFN-alpha, -beta, -epsilon, -kappa, -omega, -delta, -tau, and -gamma) and interferon-like molecules (limitin, IL-28A, IL-28B, and IL-29).<ref name="pmid15032600">{{cite journal | author = Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB | title = Interleukin-10 and related cytokines and receptors | journal = Annu. Rev. Immunol. | volume = 22 | issue = | pages = 929–79 | year = 2004 | pmid = 15032600 | doi = 10.1146/annurev.immunol.22.012703.104622 | url =  }}</ref>

==Expression and synthesis==
In humans, IL-10 is encoded by the ''IL10'' gene, which is located on [[chromosome 1 (human)|chromosome 1]] and comprises 5 [[exon]]s,<ref name="pmid9162098"/> and is primarily produced by [[monocyte]]s and, to a lesser extent, [[lymphocyte]]s, namely type 2 [[T helper cell]]s (T<sub>H</sub>2), [[mast cell|mastocyte]]s, CD4+CD25+Foxp3+ [[regulatory T cell]]s, and in a certain subset of activated [[T cell]]s and [[B cell]]s. IL-10 can be produced by monocytes upon [[Programmed cell death 1|PD-1]] triggering in these cells.<ref>Said E. A., Trautmann L., Dupuy F., Zhang Y., Ancuta P., El-Fari M., Douek D., Haddad E., and Sekaly R.-P. (2010.) Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection., ''Nature Medicine'', 452–459.</ref> The expression of IL-10 is minimal in unstimulated tissues and seems to require triggering by commensal or pathogenic flora. <ref name="pmid22438968">{{cite journal | author = Li X, Mai J, Virtue A, ''et al.'' | title = IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines. | journal = PLoS ONE | volume = 7 | issue = 3 | pages = e33628 | year = 2012 | month = March | pmid = 22438968 | doi = 10.1371/journal.pone.0033628 | url = }}</ref>

IL-10 is released by [[cytotoxic T-cell]]s to inhibit the action of [[NK cell]]s during the immune response to [[virus|viral]] [[infection]].

<ref name="pmid9162098">{{cite journal | author = Eskdale J, Kube D, Tesch H, Gallagher G | title = Mapping of the human IL10 gene and further characterization of the 5' flanking sequence | journal = Immunogenetics | volume = 46 | issue = 2 | pages = 120–8 | year = 1997 | pmid = 9162098 | doi = 10.1007/s002510050250| url = }}</ref>

==Function==
IL-10 is a cytokine with [[pleiotropic]] effects in immunoregulation and inflammation. It downregulates the expression of [[T helper cell|Th1]] cytokines, MHC class II antigens, and co-stimulatory molecules on [[macrophage]]s. It also enhances B cell survival, proliferation, and antibody production. IL-10 can block [[NF-κB]] activity, and is involved in the regulation of the [[JAK-STAT signaling pathway]].

[[Knockout mice|Knockout]] studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract.;<ref>{{cite web | title = Entrez Gene: IL10 interleukin 10| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3586| accessdate = }}</ref> and, indeed, patients with [[Crohn's disease]] react favorably towards treatment with recombinant interleukin-10-producing bacteria, demonstrating the importance of IL-10 for counteracting the [[autoimmunity|hyperactive immune response]] in the human body.<ref name="pmid16716759">{{cite journal | author = Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L | title = A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease | journal = Clin. Gastroenterol. Hepatol. | volume = 4 | issue = 6 | pages = 754–9 | year = 2006 | month = June | pmid = 16716759 | doi = 10.1016/j.cgh.2006.03.028 | url = }}</ref>

A study in mice has shown that IL-10 is also produced by [[mast cell]]s, counteracting the inflammatory effect that these cells have at the site of an [[allergic reaction]].<ref name="pmid17767162">{{cite journal | author = Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ | title = Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B | journal = Nat. Immunol. | volume = 8 | issue = 10 | pages = 1095–104 | year = 2007 | month = October | pmid = 17767162 | doi = 10.1038/ni1503 | url = }}</ref>

IL-10 is capable of inhibiting synthesis of pro-inflammatory cytokines such as [[Interferon-gamma|IFN-γ]], [[Interleukin-2|IL-2]], [[Interleukin 3|IL-3]], [[Tumor necrosis factor-alpha|TNFα]] and [[GM-CSF]] made by cells such as [[macrophages]] and regulatory T-cells. It also displays a potent ability to suppress the antigen-presentation capacity of antigen presenting cells; however, it is also stimulatory towards certain T cells (Th2) and mast cells and stimulates B cell maturation and antibody production.

===Interactions===
IL-10 has been shown to [[Protein-protein interaction|interact]] with [[Interleukin 10 receptor, alpha subunit]].<ref name=pmid8248239>{{cite journal |doi=10.1073/pnas.90.23.11267 |last=Ho |first=A S |authorlink= |coauthors=Liu Y, Khan T A, Hsu D H, Bazan J F, Moore K W |year=1993|month=Dec. |title=A receptor for interleukin 10 is related to interferon receptors |journal=[[PNAS|Proc. Natl. Acad. Sci. U.S.A.]] |volume=90 |issue=23 |pages=11267–71 |publisher= |location = UNITED STATES| issn = 0027-8424| pmid = 8248239|pmc=47963 }}</ref><ref name=pmid11485736>{{cite journal |doi=10.1016/S1074-7613(01)00169-8 |last=Josephson |first=K |authorlink= |coauthors=Logsdon N J, Walter M R |year=2001|month=Jul. |title=Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site |journal=Immunity |volume=15 |issue=1 |pages=35–46 |publisher= |location = United States| issn = 1074-7613| pmid = 11485736}}</ref><ref name=pmid7759550>{{cite journal |doi=10.1074/jbc.270.21.12906 |last=Tan |first=J C |authorlink= |coauthors=Braun S, Rong H, DiGiacomo R, Dolphin E, Baldwin S, Narula S K, Zavodny P J, Chou C C |year=1995|month=May. |title=Characterization of recombinant extracellular domain of human interleukin-10 receptor |journal=J. Biol. Chem. |volume=270 |issue=21 |pages=12906–11 |publisher= |location = UNITED STATES| issn = 0021-9258| pmid = 7759550}}</ref><ref name=pmid11717514>{{cite journal |doi=10.1107/S0907444901016249 |last=Josephson |first=K |authorlink= |coauthors=McPherson D T, Walter M R |year=2001|month=Dec. |title=Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1 |journal=Acta Crystallogr. D Biol. Crystallogr. |volume=57|issue=Pt 12|pages=1908–11|location = Denmark| issn = 0907-4449| pmid = 11717514}}</ref><ref name=pmid10231374>{{cite journal |doi=10.1046/j.1432-1327.1999.00363.x |last=Hoover |first=D M |coauthors=Schalk-Hihi C, Chou C C, Menon S, Wlodawer A, Zdanov A |year=1999|month=May. |title=Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization |journal=Eur. J. Biochem. |volume=262 |issue=1 |pages=134–41 |publisher= |location = GERMANY| issn = 0014-2956| pmid = 10231374}}</ref>

The receptor complex for IL-10 also requires the IL10R2 chain to initiate signalling. This ligand–receptor combination is found in birds and frogs, and is also likely to exist in bony fish.{{citation needed|date=August 2012}}

==References==
{{reflist}}

==Further reading==
{{refbegin | 2}}
* {{cite journal | author = Bortesi L, Rossato M, Schuster F, Raven N, Stadlmann J, Avesani L, Falorni A, Bazzoni F, Bock R, Schillberg S, Pezzotti M | title = Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco | journal = BMC Biotechnol. | volume = 9| pages = 22 | year = 2009 | pmid = 19298643 | pmc = 2667500 | doi = 10.1186/1472-6750-9-22 | url = }}
{{PBB_Further_reading 
| citations = 
*{{cite journal  | author=Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A |title=Interleukin-10 and the interleukin-10 receptor |journal=Annu. Rev. Immunol. |volume=19 |issue=  |pages= 683–765 |year= 2001 |pmid= 11244051 |doi= 10.1146/annurev.immunol.19.1.683 }}
*{{cite journal  | author=Girndt M |title=Humoral immune responses in uremia and the role of IL-10 |journal=Blood Purif. |volume=20 |issue= 5 |pages= 485–8 |year= 2003 |pmid= 12207099 |doi=10.1159/000063553  }}
*{{cite journal  | author=Beebe AM, Cua DJ, de Waal Malefyt R |title=The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS) |journal=Cytokine Growth Factor Rev. |volume=13 |issue= 4–5 |pages= 403–12 |year= 2003 |pmid= 12220553 |doi=10.1016/S1359-6101(02)00025-4  }}
*{{cite journal  | author=Mocellin S, Panelli MC, Wang E, ''et al.'' |title=The dual role of IL-10 |journal=Trends Immunol. |volume=24 |issue= 1 |pages= 36–43 |year= 2004 |pmid= 12495723 |doi=10.1016/S1471-4906(02)00009-1  }}
*{{cite journal  | author=Roncarolo MG, Battaglia M, Gregori S |title=The role of interleukin 10 in the control of autoimmunity |journal=J. Autoimmun. |volume=20 |issue= 4 |pages= 269–72 |year= 2004 |pmid= 12791310 |doi=10.1016/S0896-8411(03)00047-7  }}
*{{cite journal  | author=Groux H, Cottrez F |title=The complex role of interleukin-10 in autoimmunity |journal=J. Autoimmun. |volume=20 |issue= 4 |pages= 281–5 |year= 2004 |pmid= 12791313 |doi=10.1016/S0896-8411(03)00044-1  }}
*{{cite journal  | author=Llorente L, Richaud-Patin Y |title=The role of interleukin-10 in systemic lupus erythematosus |journal=J. Autoimmun. |volume=20 |issue= 4 |pages= 287–9 |year= 2004 |pmid= 12791314 |doi=10.1016/S0896-8411(03)00043-X  }}
*{{cite journal  | author=Asadullah K, Sabat R, Friedrich M, ''et al.'' |title=Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis |journal=Current drug targets. Inflammation and allergy |volume=3 |issue= 2 |pages= 185–92 |year= 2004 |pmid= 15180472 |doi=10.2174/1568010043343886  }}
*{{cite journal  | author=Stenvinkel P, Ketteler M, Johnson RJ, ''et al.'' |title=IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly |journal=Kidney Int. |volume=67 |issue= 4 |pages= 1216–33 |year= 2005 |pmid= 15780075 |doi= 10.1111/j.1523-1755.2005.00200.x }}
*{{cite journal  | author=Copeland KF |title=Modulation of HIV-1 transcription by cytokines and chemokines |journal=Mini reviews in medicinal chemistry |volume=5 |issue= 12 |pages= 1093–101 |year= 2006 |pmid= 16375755 |doi=10.2174/138955705774933383  }}
}}
{{refend}}

==External links==
* {{MeshName|Interleukin-10}}

{{PDB Gallery|geneid=3586}}
{{interleukins}}

<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes 
| require_manual_inspection = no 
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}

[[Category:Cytokines]]